Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
The development of colorectal cancer is a major complication for patients with chronic idiopathic colitis. Colitis-associated tumours tend to occur at a younger age and be more aggressive than sporadic colorectal cancers. While we have previously associated the presence of tumour-infiltrating lymphocytes (TILs) and increased apoptosis in sporadic colorectal cancer with high-level microsatellite instability and improved prognosis, little is known of the relationship between these variables in colitis-associated colorectal cancer. The aim of this study was to correlate TILs and tumour cell apoptosis in colitis-associated neoplasms stratified according to microsatellite instability. Twenty tumour and 11 dysplastic samples resected from 21 patients with long-standing colitis were analysed for microsatellite instability at 10 microsatellite markers. TIL distribution (CD3, CD8) and function (granzyme B) were quantified by immunohistochemistry. Neoplastic cell apoptosis was assessed using the M30 CytoDEATH antibody. These findings were compared with 40 microsatellite stable (MSS) sporadic colorectal cancers previously evaluated for TILs and neoplastic apoptosis. Low-level microsatellite instability was found in 1/20 colitis-associated tumours. All other colitis-associated lesions were designated MSS. CD3(+) and CD8(+) TIL counts were significantly higher in colitis-associated lesions compared with MSS sporadic colorectal cancer (p < 0.0001, p = 0.001 respectively). Despite their higher TIL density, colitis-associated tumours were more likely to present late (Dukes' stage C or D) (p = 0.02). Functionally, colitis-associated TILs demonstrated significantly less granzyme B expression compared to sporadic cancers (p = 0.002). The level of tumour cell apoptosis was similar between the two groups (sporadic, 1.53%; colitis cancers, 1.45%). In conclusion, MSS colitis-associated tumours have a higher prevalence of CD3(+)/CD8(+) TILs but no associated increase in tumour cell killing by apoptosis. Unlike cytotoxic T cells in sporadic colorectal cancer, TILs do not appear to enhance the prognosis of colitis-associated colorectal cancer. This may be related to an impairment of granzyme B expression within these lesions.
Michael-Robinson
J M
JM
Crohn's and Colitis Laboratory, Clinical Research Centre, Royal Brisbane and Women's Hospital Research Foundation, Queensland Institute of Medical Research, Brisbane, Australia.
Pandeya
N
N
Walsh
M D
MD
Biemer-Huttmann
A-E
AE
Eri
R D
RD
Buttenshaw
R L
RL
Lincoln
D
D
Clouston
A D
AD
Jass
J R
JR
Radford-Smith
G L
GL
D000368:Aged; D017209:Apoptosis; D018801:CD2 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D016022:Case-Control Studies; D003093:Colitis, Ulcerative / Q000150:complications / Q000276:immunology* / Q000473:pathology; D015179:Colorectal Neoplasms / Q000150:complications / Q000276:immunology* / Q000473:pathology; D004847:Epithelial Cells / Q000473:pathology; D005260:Female; D053804:Granzymes; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D016246:Lymphocytes, Tumor-Infiltrating / Q000201:enzymology / Q000276:immunology*; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012697:Serine Endopeptidases / Q000032:analysis
D018801:CD2 Antigens; D016827:CD8 Antigens; C509213:GZMB protein, human; D053804:Granzymes; D012697:Serine Endopeptidases